
Bexion Pharmaceuticals, Inc. announces data from ongoing Phase I BXQ-350 clinical trial
Covington-based Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, discussed data from 17 patients…